170 related articles for article (PubMed ID: 10428315)
1. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer.
Tanos V; Prus D; Ayesh S; Weinstein D; Tykocinski ML; De-Groot N; Hochberg A; Ariel I
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):7-11. PubMed ID: 10428315
[TBL] [Abstract][Full Text] [Related]
2. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI
Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors.
Niikura H; Sasano H; Sato S; Yajima A
Int J Gynecol Pathol; 1997 Jan; 16(1):60-8. PubMed ID: 8986534
[TBL] [Abstract][Full Text] [Related]
4. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
[TBL] [Abstract][Full Text] [Related]
5. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p21WAF1/CIP1 and MDM2 characterizes serous borderline ovarian tumors.
Palazzo JP; Monzon F; Burke M; Hyslop T; Dunton C; Barusevicius A; Capuzzi D; Kovatich AJ
Hum Pathol; 2000 Jun; 31(6):698-704. PubMed ID: 10872663
[TBL] [Abstract][Full Text] [Related]
7. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
[TBL] [Abstract][Full Text] [Related]
8. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
9. The product of the imprinted H19 gene is an oncofetal RNA.
Ariel I; Ayesh S; Perlman EJ; Pizov G; Tanos V; Schneider T; Erdmann VA; Podeh D; Komitowski D; Quasem AS; de Groot N; Hochberg A
Mol Pathol; 1997 Feb; 50(1):34-44. PubMed ID: 9208812
[TBL] [Abstract][Full Text] [Related]
10. Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.
Zheng J; Benedict WF; Xu HJ; Hu SX; Kim TM; Velicescu M; Wan M; Cofer KF; Dubeau L
J Natl Cancer Inst; 1995 Aug; 87(15):1146-53. PubMed ID: 7674319
[TBL] [Abstract][Full Text] [Related]
11. The dynamics of the imprinted H19 gene expression in the mouse model of bladder carcinoma induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Elkin M; Ayesh S; Schneider T; de Groot N; Hochberg A; Ariel I
Carcinogenesis; 1998 Dec; 19(12):2095-9. PubMed ID: 9886562
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
[TBL] [Abstract][Full Text] [Related]
13. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
[TBL] [Abstract][Full Text] [Related]
14. Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.
Shibata K; Kajiyama H; Mizokami Y; Ino K; Nomura S; Mizutani S; Terauchi M; Kikkawa F
Gynecol Oncol; 2005 Jul; 98(1):11-8. PubMed ID: 15907336
[TBL] [Abstract][Full Text] [Related]
15. The H19 gene is expressed within both epithelial and stromal components of human invasive adenocarcinomas.
Dugimont T; Curgy JJ; Wernert N; Delobelle A; Raes MB; Joubel A; Stehelin D; Coll J
Biol Cell; 1995; 85(2-3):117-24. PubMed ID: 8785513
[TBL] [Abstract][Full Text] [Related]
16. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
17. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
18. Pattern of HER-2 Gene Amplification and Protein Expression in Benign, Borderline, and Malignant Ovarian Serous and Mucinous Neoplasms.
Mohammed RAA; Makboul R; Elsers DAH; Elsaba TMAM; Thalab AMAB; Shaaban OM
Int J Gynecol Pathol; 2017 Jan; 36(1):50-57. PubMed ID: 27309616
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
Griffiths AP; Cross D; Kingston RE; Harkin P; Wells M; Quirke P
Int J Gynecol Pathol; 1993 Oct; 12(4):307-14. PubMed ID: 8253547
[TBL] [Abstract][Full Text] [Related]
20. p63 expression in epithelial ovarian tumors.
Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
